DeutschNewstral
Article
Mmarketwatch.com on 2021-01-28 22:36
Novavax stock soars more than 20% after COVID-19 vaccine study shows nearly 90% efficacy in UK, less against new South African variant
Related news
- HFresh Data Show Toll South African Variant Takes on Vaccine Efficacyhamodia.com
Novavax says its Covid-19 vaccine is 89 percent effective, but less so against South African variantPOLITICO- FSouth African Covid variant may impact vaccine efficacy, warn scientistsft.com
South African coronavirus variant may lower vaccine efficacy, 'escapes' plasma therapy: scientistsFox News
Astrazeneca vaccine only has minimal efficacy against the South African variantthewestonforum.com
Novavax says Covid-19 vaccine shows 90.4% overall efficacy in US/Mexico Phase 3 trialCNN- FBioNTech/Pfizer vaccine is less potent against South African variantft.com
'Vaccine is less effective against South African variant'israelnationalnews.com- PNovavax Covid-19 vaccine shows 85.6% efficacypendect.com
Novavax COVID-19 vaccine works, but less so against variantsoregonlive.com- HNovavax COVID-19 Vaccine Works, But Less So Against Variantshamodia.com
- BNovavax Says Its Vaccine Is 89% Effective in Britain--but Not as Effective Against the South African Variantbarrons.com
Coronavirus | Novavax claims 90% efficacy for its vaccineThe Hindu
South African study indicates people less likely to be hospitalized with Omicron variantCNN International- HIsraeli Study Shows Pfizer Vaccine Less Effective Against South African Varianthamodia.com
COVID-19: AstraZeneca vaccine less effective against South African variant — Studyvanguardngr.com
Omicron variant more resistant to vaccines but causes less severe COVID, major South African study concludespost-gazette.com